YTEN - Yield10 Bioscience GAAP EPS of -$0.68 misses by $0.03 revenue of $0.15M misses by $0.02M

Yield10 Bioscience press release (NASDAQ:YTEN): Q1 GAAP EPS of -$0.68 misses by $0.03. Revenue of $0.15M (-25.0% Y/Y) misses by $0.02M. Ended the first quarter of 2022 with $12.7 million in unrestricted cash and investments; a net decrease of $3.3 million from unrestricted cash and investments of $16.0 million reported as of December 31, 2021. Continues to estimate total net cash usage for the full year ended December 31, 2022 in a range of $12.0 to $12.5 million. Present capital resources are expected to fund planned operations into the first quarter of 2023.

For further details see:

Yield10 Bioscience GAAP EPS of -$0.68 misses by $0.03, revenue of $0.15M misses by $0.02M